ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

ESMO 2026 Exhibitors

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

235 organizations exhibit at ESMO 2026 — 145 industry and service companies, 74 drug developers, 13 societies and non-profits and 3 cancer centres and hospitals. 59 of them also present on the scientific program, with 208 presentations between them. Most represented: MD Anderson Cancer Center, Institut Curie and City of Hope. As of Nov 2, 2026.

All 1,879 organizations at ESMO 2026 →

Tumour type
Top represented
Showing 1–30 of 235 organizations
OrganizationESMO 2026 Attendance
Cancer centre & hospitalExhibitor
Comprehensive cancer treatment and research centre of the University of Texas in Houston, Texas.
Booth
Exhibiting at Booth 8006
Institut Curie
Paris, France
Cancer centre & hospitalExhibitor
Private non-profit cancer centre in Paris, France, combining a research centre with hospital sites.
Booth
Exhibiting at Booth 8042
City of Hope
Duarte, CA
Cancer centre & hospitalExhibitor
Independent cancer research and treatment organization based in Duarte, California, with an NCI-designated comprehensive cancer centre and sites across the US.
Booth
Exhibiting at Booth 8038
AstraZeneca
Cambridge, United Kingdom
Large pharmaExhibitor
Global pharmaceutical company with a large oncology portfolio including osimertinib, durvalumab, olaparib and trastuzumab deruxtecan.
Booth
Exhibiting at Booth 8066
Society & non-profitExhibitor
Independent non-profit that runs international academic cancer clinical trials across Europe.
Booth
Exhibiting at Booth S1041
CRO & servicesExhibitor
Global contract research and healthcare data company providing clinical trial services and real-world evidence.
Booth
Exhibiting at Booth 1001
Large pharmaExhibitor
British pharmaceutical company whose oncology medicines include niraparib, dostarlimab and momelotinib.
Booth
Exhibiting at Booth 1023
BiotechExhibitor
South Korean biotech developing bacteriophage and endolysin-based medicines, including phage-derived candidates for colorectal cancer.
Booth
Exhibiting at Booth 1102
Diagnostics & toolsExhibitor
Clinical laboratory company offering diagnostic testing, including oncology tests, and central-laboratory services for drug development.
Booth
Exhibiting at Booth 1088
Large pharmaExhibitor
Finnish pharmaceutical company that co-developed the prostate cancer drug darolutamide with Bayer.
Booth
Exhibiting at Booth 1047
Large pharmaExhibitor
Healthcare company whose Innovative Medicine business markets oncology drugs including amivantamab, daratumumab and teclistamab.
Booth
Exhibiting at Booth 1029 · Johnson & Johnson Innovative Medicine
Medical education & publishingExhibitor
WebMD's medical news and continuing-education service for physicians and other clinicians.
Booth
Exhibiting at Booth 8072
Abbott
Abbott Park, IL
Diagnostics & toolsExhibitor
Global healthcare company making diagnostics, medical devices and nutrition products; now owns Exact Sciences' cancer testing business.
Booth
Exhibiting at Booth 8071 · Exact Sciences
Diagnostics & toolsExhibitor
Chinese precision oncology company offering cancer genomic profiling and early detection tests.
Booth
Exhibiting at Booth 8029
Large pharmaExhibitor
US biopharmaceutical company whose oncology unit, with cell-therapy arm Kite, markets antibody-drug conjugates and CAR T therapies.
Booth
Exhibiting at Booth 8063 · Gilead and Kite Oncology
Large pharmaExhibitor
German science and technology company whose healthcare business markets oncology medicines including avelumab, cetuximab and tepotinib.
Booth
Exhibiting at Booth 1034
Large pharmaExhibitor
Swiss pharmaceutical company whose oncology medicines include ribociclib for breast cancer and radioligand therapies.
Booth
Exhibiting at Booth 1059
AbbVie
North Chicago, IL
Large pharmaExhibitor
Global biopharmaceutical company with oncology medicines including venetoclax, ibrutinib and antibody-drug conjugates.
Booth
Exhibiting at Booth 8034
Elsevier
Amsterdam, Netherlands
Medical education & publishingExhibitor
Scientific and medical publisher of journals including The Lancet and Cell, plus clinical information tools.
Booth
Exhibiting at Booth P8091
German Breast Group (GBG)
Neu-Isenburg, Germany
Society & non-profitExhibitor
German academic research organisation that designs and runs clinical trials in breast cancer.
Booth
Exhibiting at Booth 1095
BiotechExhibitor
Spanish biopharmaceutical company developing and marketing marine-derived cancer medicines, including trabectedin and lurbinectedin.
Booth
Exhibiting at Booth 1066
Diagnostics & toolsExhibitor
Chinese maker of PCR and NGS companion diagnostic kits for cancer gene alterations.
Booth
Exhibiting at Booth 8059
BioNTech
Mainz, Germany
BiotechExhibitor
German biotech developing mRNA cancer immunotherapies, antibody-drug conjugates and bispecific antibodies.
Booth
Exhibiting at Booth 8070
Medtech & supportive careExhibitor
French digital platform for remote monitoring of cancer patients' symptoms between visits.
Booth
Exhibiting at Booth 1086
Diagnostics & toolsExhibitor
Indian molecular diagnostics company making PCR and NGS test kits and instruments.
Booth
Exhibiting at Booth 1060
CRO & servicesExhibitor
Global contract research organization headquartered in Ireland, providing clinical development and trial services.
Booth
Exhibiting at Booth 8005
BiotechExhibitor
US biotech developing targeted cancer therapies, including antibody-drug conjugates and a gamma secretase inhibitor for desmoid tumours.
Booth
Exhibiting at Booth 8017
Diagnostics & toolsExhibitor
Genetic testing company whose Signatera tumour-informed ctDNA test tracks molecular residual disease and treatment response.
Booth
Exhibiting at Booth 1015
Diagnostics & toolsExhibitor
AI company building research agents and a biomedical knowledge base for drug development teams.
Booth
Exhibiting at Booth 1090
Medtech & supportive careExhibitor
Oncology company whose Tumor Treating Fields devices use electric fields to disrupt cancer cell division, used in glioblastoma, mesothelioma and lung cancer.
Booth
Exhibiting at Booth 8032

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from ESMO 2026 exhibitors

Tell us what you sell and we’ll find the people at these exhibitors most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ESMO 2026 by

Exhibit hall
  • Exhibitors 235

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction